TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. ANTIEMETICS MARKET, BY DRUG CLASS (USD BILLION)
6.1. Serotonin 5-HT3 Receptor Antagonists
6.2. Dopamine Antagonists
6.3. Antihistamines
6.4. Cannabinoids
6.5. Neurokinin-1 Receptor Antagonists
7. ANTIEMETICS MARKET, BY ROUTE OF ADMINISTRATION (USD BILLION)
7.1. Oral
7.2. Intravenous
7.3. Transdermal
7.4. Rectal
7.5. Subcutaneous
8. ANTIEMETICS MARKET, BY INDICATION (USD BILLION)
8.1. Chemotherapy-Induced Nausea
8.2. Postoperative Nausea and Vomiting
8.3. Motion Sickness
8.4. Pregnancy-Related Nausea
8.5. Radiation-Induced Nausea
9. ANTIEMETICS MARKET, BY END USER (USD BILLION)
9.1. Hospitals
9.2. Clinics
9.3. Homecare Settings
9.4. Pharmacies
10. ANTIEMETICS MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Antiemetics Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Antiemetics Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Sanofi
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. GSK
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. AbbVie
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. Genentech
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Bayer
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Eisai
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. Bristol Myers Squibb
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. Teva Pharmaceuticals
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Amgen
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Johnson and Johnson
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Pfizer
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Merck
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. Roche
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. AstraZeneca
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. Novartis
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 7. US ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 8. US ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 9. US ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 10. US ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 11. US ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 18. EUROPE ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 19. EUROPE ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. GERMANY ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 23. GERMANY ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 24. GERMANY ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 25. GERMANY ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 27. UK ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 28. UK ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 29. UK ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 30. UK ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 31. UK ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. FRANCE ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 33. FRANCE ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 34. FRANCE ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 35. FRANCE ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 36. FRANCE ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 37. RUSSIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 38. RUSSIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 39. RUSSIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 40. RUSSIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 41. RUSSIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. ITALY ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 43. ITALY ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 44. ITALY ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 45. ITALY ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 46. ITALY ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 47. SPAIN ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 48. SPAIN ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 49. SPAIN ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 50. SPAIN ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 51. SPAIN ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 52. REST OF EUROPE ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 53. REST OF EUROPE ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 54. REST OF EUROPE ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 55. REST OF EUROPE ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 56. REST OF EUROPE ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 57. APAC ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 58. APAC ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 59. APAC ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 60. APAC ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 61. APAC ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. CHINA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 63. CHINA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 64. CHINA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 65. CHINA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 66. CHINA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 67. INDIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 68. INDIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 69. INDIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 70. INDIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 71. INDIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 72. JAPAN ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 73. JAPAN ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 74. JAPAN ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 75. JAPAN ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 76. JAPAN ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 77. SOUTH KOREA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 78. SOUTH KOREA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 79. SOUTH KOREA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 80. SOUTH KOREA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 81. SOUTH KOREA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 82. MALAYSIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 83. MALAYSIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 84. MALAYSIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 85. MALAYSIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 86. MALAYSIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 87. THAILAND ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 88. THAILAND ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 89. THAILAND ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 90. THAILAND ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 91. THAILAND ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. INDONESIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 93. INDONESIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 94. INDONESIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 95. INDONESIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 96. INDONESIA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 97. REST OF APAC ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 98. REST OF APAC ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 99. REST OF APAC ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 100. REST OF APAC ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 101. REST OF APAC ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 102. SOUTH AMERICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 103. SOUTH AMERICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 104. SOUTH AMERICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 105. SOUTH AMERICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 106. SOUTH AMERICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 107. BRAZIL ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 108. BRAZIL ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 109. BRAZIL ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 110. BRAZIL ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 111. BRAZIL ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 112. MEXICO ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 113. MEXICO ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 114. MEXICO ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 115. MEXICO ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 116. MEXICO ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 117. ARGENTINA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 118. ARGENTINA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 119. ARGENTINA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 120. ARGENTINA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 121. ARGENTINA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 127. MEA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 128. MEA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 129. MEA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 130. MEA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 131. MEA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 132. GCC COUNTRIES ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 133. GCC COUNTRIES ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 134. GCC COUNTRIES ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 135. GCC COUNTRIES ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 136. GCC COUNTRIES ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 137. SOUTH AFRICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 138. SOUTH AFRICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 139. SOUTH AFRICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 140. SOUTH AFRICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 141. SOUTH AFRICA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 142. REST OF MEA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 143. REST OF MEA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 144. REST OF MEA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 145. REST OF MEA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF MEA ANTIEMETICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA ANTIEMETICS MARKET ANALYSIS
FIGURE 3. US ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 4. US ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 5. US ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 6. US ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 7. US ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 9. CANADA ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 10. CANADA ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 11. CANADA ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 12. CANADA ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE ANTIEMETICS MARKET ANALYSIS
FIGURE 14. GERMANY ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 15. GERMANY ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 16. GERMANY ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 17. GERMANY ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 18. GERMANY ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 20. UK ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 21. UK ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 22. UK ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 23. UK ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 25. FRANCE ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 26. FRANCE ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 27. FRANCE ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 28. FRANCE ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 30. RUSSIA ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 31. RUSSIA ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 32. RUSSIA ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 33. RUSSIA ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 35. ITALY ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 36. ITALY ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 37. ITALY ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 38. ITALY ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 40. SPAIN ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 41. SPAIN ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 42. SPAIN ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 43. SPAIN ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 45. REST OF EUROPE ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 46. REST OF EUROPE ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 47. REST OF EUROPE ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 48. REST OF EUROPE ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC ANTIEMETICS MARKET ANALYSIS
FIGURE 50. CHINA ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 51. CHINA ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 52. CHINA ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 53. CHINA ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 54. CHINA ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 56. INDIA ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 57. INDIA ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 58. INDIA ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 59. INDIA ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 61. JAPAN ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 62. JAPAN ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 63. JAPAN ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 64. JAPAN ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 66. SOUTH KOREA ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 67. SOUTH KOREA ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 68. SOUTH KOREA ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 69. SOUTH KOREA ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 71. MALAYSIA ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 72. MALAYSIA ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 73. MALAYSIA ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 74. MALAYSIA ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 76. THAILAND ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 77. THAILAND ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 78. THAILAND ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 79. THAILAND ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 81. INDONESIA ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 82. INDONESIA ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 83. INDONESIA ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 84. INDONESIA ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 86. REST OF APAC ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 87. REST OF APAC ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 88. REST OF APAC ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 89. REST OF APAC ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA ANTIEMETICS MARKET ANALYSIS
FIGURE 91. BRAZIL ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 92. BRAZIL ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 93. BRAZIL ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 94. BRAZIL ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 95. BRAZIL ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 97. MEXICO ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 98. MEXICO ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 99. MEXICO ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 100. MEXICO ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 102. ARGENTINA ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 103. ARGENTINA ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 104. ARGENTINA ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 105. ARGENTINA ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 107. REST OF SOUTH AMERICA ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 108. REST OF SOUTH AMERICA ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 109. REST OF SOUTH AMERICA ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 110. REST OF SOUTH AMERICA ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA ANTIEMETICS MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 113. GCC COUNTRIES ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 114. GCC COUNTRIES ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 115. GCC COUNTRIES ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 116. GCC COUNTRIES ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 118. SOUTH AFRICA ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 119. SOUTH AFRICA ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 120. SOUTH AFRICA ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 121. SOUTH AFRICA ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA ANTIEMETICS MARKET ANALYSIS BY DRUG CLASS
FIGURE 123. REST OF MEA ANTIEMETICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 124. REST OF MEA ANTIEMETICS MARKET ANALYSIS BY INDICATION
FIGURE 125. REST OF MEA ANTIEMETICS MARKET ANALYSIS BY END USER
FIGURE 126. REST OF MEA ANTIEMETICS MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF ANTIEMETICS MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF ANTIEMETICS MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: ANTIEMETICS MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: ANTIEMETICS MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: ANTIEMETICS MARKET
FIGURE 133. ANTIEMETICS MARKET, BY DRUG CLASS, 2024 (% SHARE)
FIGURE 134. ANTIEMETICS MARKET, BY DRUG CLASS, 2019 TO 2032 (USD Billions)
FIGURE 135. ANTIEMETICS MARKET, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
FIGURE 136. ANTIEMETICS MARKET, BY ROUTE OF ADMINISTRATION, 2019 TO 2032 (USD Billions)
FIGURE 137. ANTIEMETICS MARKET, BY INDICATION, 2024 (% SHARE)
FIGURE 138. ANTIEMETICS MARKET, BY INDICATION, 2019 TO 2032 (USD Billions)
FIGURE 139. ANTIEMETICS MARKET, BY END USER, 2024 (% SHARE)
FIGURE 140. ANTIEMETICS MARKET, BY END USER, 2019 TO 2032 (USD Billions)
FIGURE 141. ANTIEMETICS MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 142. ANTIEMETICS MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS
